New trial to test potential treatment for chronic kidney disease
Posted:
The first participants have been recruited in Oxford for a new multinational clinical trial that will investigate whether a novel treatment can help slow the progression of chronic kidney disease (CKD).
A global expert panel has recently announced that the condition hitherto known as polycystic ovary syndrome (PCOS) will officially undergo a name change to polyendocrine metabolic ovarian syndrome (PMOS).
Previously, doctors would diagnose the condition formerly known as PCOS based…
Isomorphic Labs, an AI drug discovery and development company, raised $2.1 billion in a Series B funding round led by Thrive Capital.
The raise was also backed by existing investors Alphabet and GV (Google Ventures) and new investors MGX, Temasek,…
Attendees
Sponsors and Exhibitors
Contact us